CD177 expression on neutrophils: In search of a clonal assay for myeloid neoplasia by flow cytometry

American Journal of Clinical Pathology

Volumn 140, Issue 5, 2013, Pages 658-669

  Meyerson, Howard J ^a   Osei, Ebeneezer ^a   Schweitzer, Karen ^a   Blidaru, Georgetta ^a   Edinger, Alison ^a   Balog, Anna ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

CD177; Flow cytometry; Myelodysplasia; Neutrophil

Indexed keywords

CD177 ANTIGEN; CYCLOSPORIN; LYMPHOCYTE ANTIGEN; RECOMBINANT ERYTHROPOIETIN; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; APLASTIC ANEMIA; ARTICLE; B CELL LYMPHOMA; BLOOD SAMPLING; BONE MARROW; CANCER CHEMOTHERAPY; CANCER STAGING; CELL POPULATION; CHILD; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; GRANULOCYTE PRECURSOR; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMMUNOPHENOTYPING; INDUCTION CHEMOTHERAPY; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; NEUTROPHIL COUNT; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

CD177; FLOW CYTOMETRY; MYELODYSPLASIA; NEUTROPHIL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; BONE MARROW CELLS; CHILD; CHILD, PRESCHOOL; CLONE CELLS; FEMALE; FLOW CYTOMETRY; GPI-LINKED PROTEINS; HUMANS; INFANT; ISOANTIGENS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEUTROPHILS; RECEPTORS, CELL SURFACE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84886238542     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPDFBEBQZW1OI7     Document Type: Article

References (43)

1. Stroncek D. Neutrophil-specific antigen HNA-2a, NB1 glycoprotein, and CD177. Curr Opin Hematol. 2007;14:688-693.
2. Stroncek DF, Shankar RA, Noren PA, et al. Analysis of the expression of NB1 antigen using two monoclonal antibodies. Transfusion. 1996;36:168-174.
3. Stroncek DF, Jaszcz W, Herr GP, et al. Expression of neutrophil antigens after 10 days of granulocyte-colony-stimulating factor. Transfusion. 1998;38:663-668.
4. Stroncek DF, Shankar R, Litz C, et al. The expression of the NB1 antigen on myeloid precursors and neutrophils from children and umbilical cords. Transfus Med. 1998;8:119-123.
5. Matsuo K, Lin A, Procter JL, et al. Variations in the expression of granulocyte antigen NB1. Transfusion. 2000;40:654-662.
6. Stroncek D. Neutrophil-specific antigen HNA-2a (NBI, CD177): serology, biochemistry, and molecular biology. Vox Sang. 2002;83(suppl 1):359-361.
7. Wolff J, Brendel C, Fink L, et al. Lack of NB1 GP (CD177/HNA-2a) gene transcription in NB1 GP-neutrophils from NB1 GP-expressing individuals and association of low expression with NB1 gene polymorphisms. Blood. 2003;102:731-733.
8. Stroncek DF, Caruccio L, Bettinotti M. CD177: a member of the Ly-6 gene superfamily involved with neutrophil proliferation and polycythemia vera. J Transl Med. 2004;2:8.
9. Goldschmeding R, van Dalen CM, Faber N, et al. Further characterization of the NB 1 antigen as a variably expressed 56-62 kD GPI-linked glycoprotein of plasma membranes and specific granules of neutrophils. Br J Haematol. 1992;81:336-345.
10. Kissel K, Santoso S, Hofmann C, et al. Molecular basis of the neutrophil glycoprotein NB1 (CD177) involved in the pathogenesis of immune neutropenias and transfusion reactions. Eur J Immunol. 2001;31:1301-1309.
11. Bux J. Human neutrophil alloantigens. Vox Sang. 2008;94:277-285.
12. Sachs UJ, Andrei-Selmer CL, Maniar A, et al. The neutrophilspecific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). J Biol Chem. 2007;282:23603-23612.
13. Bayat B, Werth S, Sachs UJ, et al. Neutrophil transmigration mediated by the neutrophil-specific antigen CD177 is influenced by the endothelial S536N dimorphism of platelet endothelial cell adhesion molecule-1. J Immunol. 2010;184:3889-2896.
14. Bauer S, Abdgawad M, Gunnarsson L, et al. Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils. J Leukoc Biol. 2007;81:458-464.
15. von Vietinghoff S, Tunnemann G, Eulenberg C, et al. NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils. Blood. 2007;109:4487-4493.
16. Klippel S, Strunck E, Busse CE, et al. Biochemical characterization of PRV-1, a novel hematopoietic cell surface receptor, which is overexpressed in polycythemia rubra vera. Blood. 2002;100:2441-2448.
17. Caruccio L, Bettinotti M, Director-Myska AE, et al. The gene overexpressed in polycythemia rubra vera, PRV-1, and the gene encoding a neutrophil alloantigen, NB1, are alleles of a single gene, CD177, in chromosome band 19q13.31. Transfusion. 2006;46:441-447.
18. Klippel S, Strunck E, Temerinac S, et al. Quantification of PRV-1 mRNA distinguishes polycythemia vera from secondary erythrocytosis. Blood. 2003;102:3569-3574.
19. Tefferi A, Lasho TL, Wolanskyj A, et al. Neutrophil PRV-1 expression across the chronic myeloproliferative disorders and in secondary or spurious polycythemia. Blood. 2004;103:3547-3548.
20. Liu E, Jelinek J, Pastore YD, et al. Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin. Blood. 2003;101:3294-3301.
21. Tefferi A, Sirhan S, Lasho TL, et al. Concomitant neutrophil JAK2V617F mutation screening and PRV-1 expression analysis in myeloproliferative disorders and secondary polycythaemia. Br J Haematol. 2005;131:166-171.
22. Temerinac S, Klippel S, Strunck E, et al. Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera. Blood. 2000;95:2569-2576.
23. Caruccio L, Walkovich K, Bettinotti M, et al. CD177 polymorphisms: correlation between high-frequency single nucleotide polymorphisms and neutrophil surface protein expression. Transfusion. 2004;44:77-82.
24. Stroncek D. Granulocyte gene polymorphisms and mutations: effects on immune response and neutrophil proliferation. Vox Sang. 2004;87(suppl 2):S101-S104.
25. Moritz E, Chiba AK, Kimura EY, et al. Molecular studies reveal that A134T, G156A and G1333A SNPs in the CD177 gene are associated with atypical expression of human neutrophil antigen-2. Vox Sang. 2010;98:160-166.
26. Jelinek J, Li J, Mnjoyan Z, et al. Epigenetic control of PRV-1 expression on neutrophils. Exp Hematol. 2007;35:1677-1683.
27. Taniguchi K, Nagata H, Katsuki T, et al. Significance of human neutrophil antigen-2a (NB1) expression and neutrophil number in pregnancy. Transfusion. 2004;44:581-585.
28. Caruccio L, Bettinotti M, Matsuo K, et al. Expression of human neutrophil antigen-2a (NB1) is increased in pregnancy. Transfusion. 2003;43:357-363.
29. Gohring K, Wolff J, Doppl J, et al. Neutrophil CD177 (NB1gp, HNA-2a) expression is increased in severe bacterial infections and polycythaemia vera. Br J Haematol. 2004;126:252-254.
30. Kissel K, Scheffler S, Kerowgan M, et al. Molecular basis of NB1 (HNA-2a, CD177) deficiency. Blood. 2002;99:4231-4233.
31. Thurau AM, Schylz U, Wolf V, et al. Identification of eosinophils by flow cytometry. Cytometry. 1996;23:150-158.
32. Berliner N, Ault KA, Martin P, et al. Detection of clonal excess in lymphoproliferative disease by k/l analysis: correlation with immunoglobulin gene DNA rearrangement. Blood. 1986;67:80-85.
33. Langerak AW, van Den Beemd R, Wolvers-Tettero IL, et al. Molecular and flow cytometric analysis of the Vb repertoire for clonality assessment in mature TCRab T-cell proliferations. Blood. 2001;98:165-173.
34. Epling-Burnette PK, Painter JS, Chaurasia P, et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood. 2004;103:3431-3439.
35. Sirhan S, Lasho TL, Elliott MA, et al. Neutrophil polycythemia rubra vera-1 expression in classic and atypical myeloproliferative disorders and laboratory correlates. Haematologica. 2005;90:406-408.
36. Johansson P, Ricksten A, Wasslavik C, et al. The effects of hydroxyurea on PRV-1 expression in patients with essential thrombocythemia and polycythemia vera. Haematologica. 2004;89:1264-1266.
37. Zoi K, Terpos E, Zoi C, et al. Increased CD177 (PRV1) expression in thalassaemia and the underlying erythropoietic activity. Br J Haematol. 2008;141:100-104.
38. Bock O, Serinsoz E, Neusch M, et al. The polycythaemia rubra vera-1 gene is constitutively expressed by bone marrow cells and does not discriminate polycythaemia vera from reactive and other chronic myeloproliferative disorders. Br J Haematol. 2003;123:472-474.
39. Montaser LM, El-Rashidi FH, Essa ES, et al. Analysis of CD177 neutrophil expression in b-thalassemia patients. APMIS. 2011;119:674-680.
40. Abdgawad M, Gunnarsson L, Bengtsson AA, et al. Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression. Clin Exp Immunol. 2010;161:89-97.
41. Hu N, Westra J, Huitema MG, et al. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody- associated systemic vasculitis: antiproteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils. Arthritis Rheum. 2009;60:1548-1557.
42. Kern W, Bacher U, Schnittger S, et al. Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/MPNs. Cytometry B Clin Cytom. 2013;84:194-197.
43. Loken MR, Wells DA. The role of flow cytometry in myelodysplastic syndromes. J Natl Compr Cancer Netw. 2008;6:935-941.